Eureka Therapeutics, Inc.

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Emily Semon, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eureka Therapeutics, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Estrella Immunopharma, Inc. 10%+ Owner Common Stock 25,277,831 29 Sep 2023 Direct

Insider Reports Filed by Eureka Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ESLA Estrella Immunopharma, Inc. 29 Sep 2023 0 $0 3 10%+ Owner 10 Oct 2023, 16:15